People | June 03, 2022
Sanofi India appoints Preeti Futnani as GM, Vaccines
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Auld is a seasoned Financial Executive with over 30 years of relevant experience
This agreement is in addition to the $92 million filling line expansion announced in November 2021
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
Subscribe To Our Newsletter & Stay Updated
